// App-Quantinova.ai

SAT0257 (2017) : “AIMING FOR THE BULLSEYE”: RETINAL TOXICITY SCREENING FOR HYDROXYCHLOROQUINE THERAPY – ARE WE HITTING THE TARGET?

Researchers

Presenter

  • S. Gubbins

Principal Investigators

  • J. Steen

  • A. Gorman

  • S. Khan

  • A. Mohammad

  • K. O'Rourke

Medical Centers

  • Rheumatology, Midlands Regional Hospital, Tullamore, Co Offaly, Ireland

Locations

  • Ireland

Companies

  • N/A

Study Components

Therapeutic Area

  • N/A

Disease

  • N/A

Biomarkers

  • N/A

Drug/Treatment

  • Hydroxychloroquine

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved